| 2019 | Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc | GL |
| 2019 | OSIRIS SHAREHOLDER NOTICE : Faruqi & Faruqi, LLP Announces an Investigation of Osiris Ther.. | PR |
| 2019 | WeissLaw LLP Investigates Osiris Therapeutics, Inc. | PR |
| 2019 | Monteverde & Associates PC Announces an Investigation of Osiris Therapeutics, Inc. - OS.. | PR |
| 2019 | ALERT : Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc. | PR |
| 2019 | OSIRIS THERAPEUTICS, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout | BU |
| 2019 | Smith & Nephew to buy Osiris in regenerative products push | RE |
| 2019 | OSIRIS THERAPEUTICS : Smith & Nephew expands in high growth regenerative medicine market t.. | PR |
| 2019 | Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc | GL |
| 2019 | HAGENS BERMAN : Notice to Osiris Therapeutics, Inc. Investors: Less than One Week Left to .. | BU |
| 2019 | OSIRIS THERAPEUTICS : Hagens Berman Notifies Osiris Therapeutics, Inc. Investors of Class .. | BU |
| 2018 | Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief.. | GL |
| 2018 | Osiris Therapeutics, Inc Reports Third Quarter 2018 Results | GL |
| 2018 | Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO | GL |
| 2017 | Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation | GL |
| 2017 | Osiris Therapeutics, Inc. Provides Update on Audit of 2015 and 2016 Financial Statement.. | GL |
| 2017 | Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrob.. | GL |
| 2017 | Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including.. | GL |
| 2017 | Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes f.. | GL |
| 2017 | Osiris Appoints Linda Palczuk to serve as its President & CEO | GL |
| 2017 | OSIRIS ANNOUNCES ELECTRONICALLY AVAI : Open Surgical Implantation of a Viable Cryopreser.. | GL |
| 2017 | Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tiss.. | GL |
| 2017 | Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including.. | GL |
| 2017 | Osiris Therapeutics Announces Change in its Board of Directors | GL |
| 2017 | Osiris Therapeutics Launches Prestige™ Lyotechnology, a Novel Method for Ambient .. | GL |
| 2017 | Osiris Therapeutics, Inc. Completes Restatement of 2014 Financial Statements | GL |
| 2017 | Osiris Receives Notice of Delisting from NASDAQ | GL |
| 2017 | Osiris Appoints Uwe Sommer and Thomas Knapp to its Board of Directors | GL |
| 2017 | Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of Two Human.. | GL |
| 2017 | Osiris Therapeutics Announces Scientific Manuscript Reporting Antimicrobial Properties .. | GL |
| 2016 | Osiris Provides Update Regarding NASDAQ Listing Matters | GL |
| 2016 | Peer-reviewed Publication on the use of Grafix® in High-Risk Peripheral Arterial Diseas.. | GL |
| 2016 | Osiris Provides Update Regarding NASDAQ Listing Matters | GL |
| 2016 | Osiris Therapeutics, Inc. Reports Preliminary 2014 and 2015 Revenue and Anticipated 201.. | GL |
| 2016 | OSIRIS THERAPEUTICS : Grafix® Cost Comparative Manuscript Reporting Wound Care Cost Reduct.. | PU |
| 2016 | OSIRIS THERAPEUTICS : Peer-reviewed Publication on the use of Grafix® Prime for Outpatient.. | PU |
| 2016 | Peer-reviewed Publication on the use of Grafix® Prime for Outpatient Management of Comp.. | GL |
| 2016 | Grafix® Cost Comparative Manuscript Reporting Wound Care Cost Reduction is Available El.. | GL |
| 2016 | Osiris to Present Clinical and Scientific Studies at Desert Foot 2016 | GL |
| 2016 | Net Health and Osiris Therapeutics Announce the Broad Availability of Grafix® to Wound .. | GL |
| 2016 | Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Of.. | GL |
| 2016 | Osiris to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care (.. | GL |
| 2016 | Osiris Therapeutics to Present at 2016 Cell & Gene Meeting on the Mesa | GL |
| 2016 | Osiris Provides Update Regarding NASDAQ Listing Status | GL |
| 2016 | Osiris Provides Update Regarding NASDAQ Listing Matters | GL |
| 2016 | Grafix® Manuscript Reporting Positive Outcomes of Multicenter Chronic Complex Wounds wi.. | GL |
| 2016 | Khang & Khang LLP Announces an Investigation of Claims against Osiris Therapeutics, Inc.. | BU |
| 2016 | Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Secu.. | BU |
| 2016 | Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Osiris Therapeutics, Inc. | PR |
| 2016 | Investigation of Osiris Therapeutics, Inc. Announced by Law Offices of Howard G. Smith | BU |
| 2016 | OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters | BU |
| 2016 | OSIRIS THERAPEUTICS : to Present at the 26th European Wound Management Association Confere.. | BU |
| 2016 | OSIRIS THERAPEUTICS : Grafix Demonstrates Superior Clinical Outcomes Compared with EpiFix .. | PU |
| 2016 | OSIRIS THERAPEUTICS : Grafix Demonstrates Superior Clinical Outcomes Compared with EpiFix .. | BU |
| 2016 | OSIRIS THERAPEUTICS : to Present 15 Advanced Clinical and Scientific Abstracts | BU |
| 2016 | OSIRIS THERAPEUTICS : Announces Further Expansion of Grafix Commercial Coverage | BU |
| 2016 | OSIRIS THERAPEUTICS : Announces Receipt of Deficiency Letter from NASDAQ | BU |
| 2016 | OSIRIS THERAPEUTICS : to Present at the 4th Annual Cell and Gene Therapy Investor Day | BU |
| 2016 | OSIRIS THERAPEUTICS : Provides an Update on a Clinical Review by Blue Cross Blue Shield As.. | BU |
| 2016 | OSIRIS THERAPEUTICS : Faruqi & Faruqi, LLP : is Investigating Osiris Therapeutics, Inc. (O.. | PR |
| 2016 | OSIRIS THERAPEUTICS : Grafix Demonstrates Positive Clinical Outcomes in Chronic Complex Wo.. | BU |
| 2016 | OSIRIS THERAPEUTICS : Confirms Dwayne Montgomery, as President and Chief Executive Officer.. | BU |
| 2016 | OSIRIS THERAPEUTICS : Announces Leadership Transition | BU |
| 2016 | OSIRIS THERAPEUTICS : Announces 100% Medicare Coverage for Grafix | BU |
| 2016 | OSIRIS THERAPEUTICS : Responds to Statements about the Company Recently Posted to Several .. | BU |
| 2016 | OSIRIS THERAPEUTICS : January 22 Deadline Alert: Law Offices of Howard G. Smith Reminds Os.. | BU |
| 2016 | OSIRIS THERAPEUTICS : Provides Update on Coverage for Grafix® | BU |
| 2015 | OSIRIS THERAPEUTICS (OSIR) MISLED SH : Osiris Therapeutics, Inc. (OSIR) Misled Shareholder.. | BU |
| 2015 | SHAREHOLDER ALERT : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action A.. | PR |
| 2015 | OSIRIS THERAPEUTICS : Pomerantz Law Firm Investigates Claims On Behalf of Osiris Therapeut.. | PR |
| 2015 | OSIRIS THERAPEUTICS : to Present at the 27th Annual Piper Jaffray Healthcare Conference | BU |
| 2015 | OSIRIS THERAPEUTICS : Law Offices of Howard G. Smith : Commences Investigation on Behalf o.. | BU |
| 2015 | OSIRIS THERAPEUTICS : IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces an Ongoing In.. | BU |
| 2015 | OSIRIS THERAPEUTICS : IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces an Ongoing In.. | BU |
| 2015 | OSIRIS THERAPEUTICS : Robbins Arroyo LLP : Is Investigating the Officers and Directors of .. | BU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
